Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Sarcomas: Unique Cancers that Merit Further Attention and Research

    Sarcomas are unique compared to other types of cancer variations. In contrast to carcinomas, which arise from…
    July 20, 2023| Max Mallet
  • Why Do We Get Cancer? How Our Lifestyles Impact Our Risk

    There are many factors that dictate whether someone will develop cancer, and they fall roughly into two…
    July 6, 2023| Max Mallet
  • AACR 2023 Recap: CRI Scientists Tackle the Frontiers of Cancer Immunotherapy

    More than any conference yet, the 2023 annual meeting of the American Association for Cancer Research (AACR…
    April 20, 2023| Arthur N. Brodsky, PhD
  • AACR 2023 Preview: Advancing the Frontiers of Cancer Science and Medicine

    From April 14-19, the 2023 AACR annual meeting highlights a broad scope of immunotherapy breakthroughs, including cell…
    April 10, 2023| Arthur N. Brodsky, PhD
  • A Conversation with CRI ImmunoAdvocate Karen Peterson

    Karen Peterson shares her journey from an immunotherapy clinical trial to patient advocate working to improve clinical…
    February 23, 2023| Arthur N. Brodsky, PhD
  • 5 Things Patients, Caregivers, and Families Need to Know About Cancer

    Our CEO speaks with Medium/Authority Magazine about cancer, immunotherapy, and how she became CEO of the world’s…
    December 22, 2022| Max Mallet
  • Engineering Better CAR T Cells with CRI Lloyd J. Old STAR Yvonne Chen

    CRI STAR Yvonne Chen is exploring several strategies to improve the safety and effectiveness of CAR T…
    December 19, 2022| Max Mallet
  • Clinical Trials Drive Immunotherapy Progress. Are They for You?

    Immunotherapy clinical trials are critical endeavors that lead to breakthrough cancer treatments. 

    May 19, 2022| Max Mallet
  • Dr. Dmitriy Zamarin Answers Questions About Ovarian Cancer and Immunotherapy after the 2021 CRI Virtual Immunotherapy Patient Summit

    Dr. Dmitriy Zamarin, of Memorial Sloan Kettering Cancer Center, answers questions about immunotherapy clinical trials from the…

    December 14, 2021| CRI Staff
Previous Page
1 … 7 8 9 10 11 … 15
Next Page

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal